secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001477932-23-003275
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health signs SPA to buy Cana Holdings for €800k cash + $800k stock
-------------------------------------------------------------------------

- Purchase price: €800,000 cash and 46,377 restricted shares at $17.25/share ($800,000) paid pro rata to sellers.
- Target is Pharmaceutical Laboratories Cana S.A., a Greek pharma company focused on branded products.
- Closing conditions include due diligence, audited 2022 financials, debt cap of €1M (excl. prior €4.1M Note), and no material adverse changes.
- Closing targeted by May 31, 2023; Buyer has 30-day due diligence period after receiving all items to terminate at its sole discretion.
- Sellers prohibited from soliciting other acquisition proposals; agreement includes standard reps, warranties, and indemnification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223003275/0001477932-23-003275-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223003275/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-003275

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer